Molecular studies identified that knockdown of S100A16 in both MCF7 and SKBr3 cell lines suppressed their invasive potential, further demonstrating the importance of S100A16 in potentiating metastatic capacity in breast cancer [14]. Here, S100A16 is linked to breast cancer.